» Articles » PMID: 29097752

Fragment-based Screening Identifies Novel Targets for Inhibitors of Conjugative Transfer of Antimicrobial Resistance by Plasmid PKM101

Overview
Journal Sci Rep
Specialty Science
Date 2017 Nov 4
PMID 29097752
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

The increasing frequency of antimicrobial resistance is a problem of global importance. Novel strategies are urgently needed to understand and inhibit antimicrobial resistance gene transmission that is mechanistically related to bacterial virulence functions. The conjugative transfer of plasmids by type IV secretion systems is a major contributor to antimicrobial resistance gene transfer. Here, we present a structure-based strategy to identify inhibitors of type IV secretion system-mediated bacterial conjugation. Using differential scanning fluorimetry we screened a fragment library and identified molecules that bind the essential TraE protein of the plasmid pKM101 conjugation machinery. Co-crystallization revealed that fragments bind two alternative sites of the protein and one of them is a novel inhibitor binding site. Based on the structural information on fragment binding we designed novel small molecules that have improved binding affinity. These molecules inhibit the dimerization of TraE, bind to both inhibitor binding sites on TraE and inhibit the conjugative transfer of plasmid pKM101. The strategy presented here is generally applicable for the structure-based design of inhibitors of antimicrobial resistance gene transfer and of bacterial virulence.

Citing Articles

Inner membrane components of the plasmid pKM101 type IV secretion system TraE and TraD are DNA-binding proteins.

Jemouai Z, Sverzhinsky A, Sygusch J, Pascal J, Baron C Sci Rep. 2025; 15(1):7530.

PMID: 40032854 PMC: 11876611. DOI: 10.1038/s41598-025-85446-9.


Structural and functional diversity of type IV secretion systems.

Costa T, Patkowski J, Mace K, Christie P, Waksman G Nat Rev Microbiol. 2023; 22(3):170-185.

PMID: 37814112 PMC: 11290344. DOI: 10.1038/s41579-023-00974-3.


A bottom-up view of antimicrobial resistance transmission in developing countries.

Ikhimiukor O, Odih E, Donado-Godoy P, Okeke I Nat Microbiol. 2022; 7(6):757-765.

PMID: 35637328 DOI: 10.1038/s41564-022-01124-w.


Type IV secretion systems: Advances in structure, function, and activation.

Costa T, Harb L, Khara P, Zeng L, Hu B, Christie P Mol Microbiol. 2020; 115(3):436-452.

PMID: 33326642 PMC: 8026593. DOI: 10.1111/mmi.14670.


Type IV Coupling Proteins as Potential Targets to Control the Dissemination of Antibiotic Resistance.

Alvarez-Rodriguez I, Arana L, Ugarte-Uribe B, Gomez-Rubio E, Martin-Santamaria S, Garbisu C Front Mol Biosci. 2020; 7:201.

PMID: 32903459 PMC: 7434980. DOI: 10.3389/fmolb.2020.00201.


References
1.
Gillespie J, Phan I, Scheib H, Subramanian S, Edwards T, Lehman S . Structural Insight into How Bacteria Prevent Interference between Multiple Divergent Type IV Secretion Systems. mBio. 2015; 6(6):e01867-15. PMC: 4676284. DOI: 10.1128/mBio.01867-15. View

2.
Silvestre H, Blundell T, Abell C, Ciulli A . Integrated biophysical approach to fragment screening and validation for fragment-based lead discovery. Proc Natl Acad Sci U S A. 2013; 110(32):12984-9. PMC: 3740835. DOI: 10.1073/pnas.1304045110. View

3.
Chandran V, Fronzes R, Duquerroy S, Cronin N, Navaza J, Waksman G . Structure of the outer membrane complex of a type IV secretion system. Nature. 2009; 462(7276):1011-5. PMC: 2797999. DOI: 10.1038/nature08588. View

4.
Ruer S, Pinotsis N, Steadman D, Waksman G, Remaut H . Virulence-targeted Antibacterials: Concept, Promise, and Susceptibility to Resistance Mechanisms. Chem Biol Drug Des. 2015; 86(4):379-99. DOI: 10.1111/cbdd.12517. View

5.
Smith M, Coincon M, Paschos A, Jolicoeur B, Lavallee P, Sygusch J . Identification of the binding site of Brucella VirB8 interaction inhibitors. Chem Biol. 2012; 19(8):1041-8. DOI: 10.1016/j.chembiol.2012.07.007. View